For citations:
Bakulin I.G., Bokhan N.A., Bogomolov P.O., Geyvandova N.I., Matsiyevich M.V., Vinnikova M.A., Morozov V.G., Khromtsova O.M., Soldatova G.S., Shiryayev O.Yu., Ilyuk R.D., Rybakova K.V., Katkovskaya A.G., Teplykh S.V., Bagretsova A.A., Krasnova M.V., Alekseyeva Ye.V., Anipchenko A.V., Baskakov Ye.V. Efficacy and safety of glycyrrhizic acid and essential phospholipids (Phosphogliv) combination for alcoholic liver disease: results of the double-blind randomized placebo-controlled multicenter post-registration (phase IV) clinical trial «Jaguar» (PHG-M2/P03-12). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(3):57-68. (In Russ.) https://doi.org/10.22416/1382-4376-2017-27-3-57-68
Email this article 
